Erik Koenig
- Molecular Biology
- Hematology top 5%
- Oncology
- Epidemiology
- Cancer Research top 10%
- Co-authors
- Paul G. RichardsonYongsheng HuangJohn D. ShaughnessyGeorge MulliganDixie‐Lee EsseltineSteven RoelsAllison BergerAnthony Boral
- Topics
- Ubiquitin and proteasome pathways (11 papers)Protein Degradation and Inhibitors (6 papers)Peptidase Inhibition and Analysis (3 papers)
- Journals
- The EMBO JournalBloodPLoS ONE
- Partner nations
- United StatesNetherlandsJapan
In The Last Decade
Erik Koenig
18 papers receiving 872 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 676
- Hematology 218
- Oncology 212
- Epidemiology 208
- Cancer Research 185
Countries citing papers authored by Erik Koenig
This map shows the geographic impact of Erik Koenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Koenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Koenig more than expected).
Fields of papers citing papers by Erik Koenig
This network shows the impact of papers produced by Erik Koenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Koenig. The network helps show where Erik Koenig may publish in the future.
Co-authorship network of co-authors of Erik Koenig
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Koenig. A scholar is included among the top collaborators of Erik Koenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Koenig. Erik Koenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 47 | |
| 5 | 49 | |
| 6 | 33 | |
| 7 | 14 | |
| 8 | 35 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 0 | |
| 14 | 270 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 302 | |
| 19 | 128 |
About Erik Koenig
Erik Koenig is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 19 papers that have together received 893 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Protein Degradation and Inhibitors (6 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Hematology (218 citations), Cancer Research (185 citations) and Molecular Biology (676 citations). Erik Koenig has collaborated with scholars based in United States, Netherlands and Japan. Frequent co-authors include Paul G. Richardson, Yongsheng Huang, John D. Shaughnessy, George Mulligan, Dixie‐Lee Esseltine, Steven Roels, Allison Berger, Anthony Boral, Fenghuang Zhan and P. Leif Bergsagel. Their work appears in journals such as The EMBO Journal, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.